Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

DIDANOSINE

DIDANOSINE

Standard Dose
10MG/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview DIDANOSINE is listed in Drugs@FDA under application 078112 (ANDA).

Marketing status: Discontinued Active ingredient DIDANOSINE Form and strength FOR SOLUTION;ORAL - 10MG/ML Sponsor AUROBINDO PHARMA Submission history Latest submission status date: 2012-01-31 00:00:00.

Structured Monograph

Clinical summary

Approval overview DIDANOSINE is listed in Drugs@FDA under application 078112 (ANDA). Marketing status: Discontinued Active ingredient DIDANOSINE Form and strength FOR SOLUTION;ORAL - 10MG/ML Sponsor AUROBINDO PHARMA Submission history Latest submission status date: 2012-01-31 00:00:00. Submission type: SUPPL.

Monitoring

  • Review priority: STANDARD
  • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.